keyword
MENU ▼
Read by QxMD icon Read
search

renvela

keyword
https://www.readbyqxmd.com/read/24811546/sevelamer-carbonate-a-review-in-hyperphosphataemia-in-adults-with-chronic-kidney-disease
#1
REVIEW
Caroline M Perry, Greg L Plosker
Sevelamer carbonate (Renvela(®)), a buffered form of sevelamer hydrochloride (Renagel(®)), is an orally administered non-absorbed phosphate-binding anion exchange resin used in the treatment of hyperphosphataemia in chronic kidney disease (CKD). In the EU, sevelamer carbonate is approved in adult CKD patients who require dialysis and in those who do not require dialysis with serum phosphate levels ≥ 1.78 mmol/L, whereas in the USA sevelamer carbonate is approved in adult CKD patients who require dialysis...
May 2014: Drugs
https://www.readbyqxmd.com/read/24198624/update-and-critical-appraisal-of-sevelamer-in-the-management-of-chronic-renal-failure
#2
REVIEW
Jacob Grinfeld, Akimichi Inaba, Alastair J Hutchison
Sevelamer (Renagel and Renvela), is an orally administered weakly basic anion exchange resin that binds dietary phosphate in the gastrointestinal tract, and is approved for use in the US, Europe and many other countries for the treatment of hyperphosphatemia in adult patients on hemodialysis or peritoneal dialysis. Clinical evidence shows that sevelamer is at least as effective as calcium-based oral phosphate binders in controlling serum phosphate, but with a lower incidence of hypercalcemia. Whilst sevelamer hydrochloride is associated with mild acidosis, sevelamer carbonate does not have this drawback...
2010: Open Access Journal of Urology
https://www.readbyqxmd.com/read/24061514/sevelamer-crystals-in-the-gastrointestinal-tract-git-a-new-entity-associated-with-mucosal-injury
#3
MULTICENTER STUDY
Benjamin J Swanson, Berkeley N Limketkai, Ta-Chiang Liu, Elizabeth Montgomery, Kamran Nazari, Jason Y Park, William C Santangelo, Michael S Torbenson, Lysandra Voltaggio, Martha M Yearsley, Christina A Arnold
We report the first description of sevelamer crystals (Renagel and Renvela, Genzyme; phosphate-lowering agents) in the gastrointestinal tract. We prospectively collected cases with novel, histologically identical crystals from 4 major academic centers over a 1-year period and studied pertinent clinicopathologic features. Sevelamer usage in the setting of chronic kidney disease was demonstrated in all cases (n=15 total cases, 7 patients). Sites of involvement included the esophagus (n=2), small bowel (n=2), and colon (n=11)...
November 2013: American Journal of Surgical Pathology
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"